Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2003
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003010361A3 Nitrogen atom transfer
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149262 Benzodiazepine vitronectin receptor antagonist pharmaceuticals
08/07/2003US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis
08/07/2003US20030149050 Inhibitors of inflammation and reperfusion injury and methods of use thereof
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149046 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149041 For prophylaxis and therapy of inflammation, asthma, arthritis, diabetes, atherosclerosis, ocular diseases, restenosis, autoimmune responses, multiple sclerosis, psoriasis, human cancers, fibrosis of liver, lung and kidney
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149028 Pesticidal compositions
08/07/2003US20030149022 Inhibiting beta -amyloid peptide release and/or its synthesis in a cell by administering deoxyamino acid compound
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473803A1 Substituted indoles as alpha-1 agonists
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1332141A1 Quinazoline derivatives
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332135A1 Tagging compounds and process for use in aida libraries
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0799209B1 Sulfonamides
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117083C Pyradazin-3-one derivatives, their use, and intermediates for their production
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/05/2003US6602895 Inhibitors of factor Xa with a neutral P1 specificity group
08/05/2003US6602883 Inhibitors of farnesyl protein transferase
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602248 Methods for repairing damaged intervertebral discs
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/05/2003CA2079373C (azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062251A1 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062226A1 Quinazoline(di) ones for invertebrate pest control
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062212A1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062205A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
07/31/2003WO2003062171A2 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
07/31/2003WO2003061657A1 5-ht3 receptor antagonists and methods of use
07/31/2003WO2003061653A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
07/31/2003WO2003061652A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/31/2003WO2003061651A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
07/31/2003WO2003061632A1 Method of treatment of a patient requiring analgesia
07/31/2003WO2003047516A3 Pyrimidine compounds
07/31/2003WO2003039460A3 Mitotic kinesin inhibitors
07/31/2003WO2002092065A3 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
07/31/2003WO2002040471A9 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
07/31/2003US20030144506 Formula 1 are useful in treating abnormal cell growth in mammals by administering pharmaceutical compositions.
07/31/2003US20030144337 Pyrazole-derived kinase inhibitors and uses thereof
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists
07/31/2003US20030144309 Inhibitors of Src and other protein kinases
07/31/2003US20030144308 Fructose 1,6-bisphosphatase inhibitors
07/31/2003US20030144303 Aminopyrimidine and aminopyridine anti-inflammation agents
07/31/2003US20030144302 Process for making substituted pyrazoles
07/31/2003US20030144300 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
07/31/2003US20030144297 Substituted aryl 1,4-pyrazine derivatives
07/31/2003US20030144295 A synergistic antiischemic mixture of a tissue plasminogen activator, e.g. alteplase, pamiteplase, and zonampanel(7-imidazol-1-yl-6-nitro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin -1-yl acetic acid for strokes or cerebral infarctions
07/31/2003US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
07/31/2003US20030144287 Heterocyclic amides such as N-(4-(2-(((methyl)amino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-1-(3-amino-1,2-benzisoxazol-5-yl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide, used as anticoagulants; prophylaxis of cardiovascular disorders
07/31/2003US20030144286 Nitrogen compounds such as 3-nitro-N-(1H-benzoimidazol-2-yl)-benzamide, used as nonsteroidal antiinflammatory agents, immunology or interleukin receptor associated kinase (IRAK) modulators; rheumatic diseases; multiple sclerosis
07/31/2003US20030144284 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents
07/31/2003US20030144282 Inhibitors of cytosolic phospholipase A2
07/31/2003US20030144279 5-Heterocyclo-pyrazoles
07/31/2003US20030144277 Piperizinones as modulators of chemokine receptor activity
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/31/2003US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics
07/31/2003US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents
07/31/2003US20030144267 Novel compounds
07/31/2003US20030144264 Carbapenems containing a carboxy substituted phenyl group and useful for treating bacterial infections in mammals and humans
07/31/2003US20030144262 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes
07/31/2003US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases
07/31/2003US20030144250 Triazole derivatives useful in therapy
07/31/2003US20030144175 Protease inhibitors
07/31/2003US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
07/31/2003US20030143185 Polymer conjugates of protein kinase C inhibitors
07/31/2003CA2473884A1 Method of treatment of a patient requiring analgesia
07/31/2003CA2473796A1 Substituted quinazolin-4-ylamine analogues
07/31/2003CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003CA2473392A1 5-ht3 receptor antagonists and methods of use
07/31/2003CA2472239A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
1 ... 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 ... 626